The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy
|
---|---|
Published in |
Frontiers in oncology, December 2021
|
DOI | 10.3389/fonc.2021.770022 |
Pubmed ID | |
Authors |
Joanne Lundy, Marion Harris, John Zalcberg, Allan Zimet, David Goldstein, Val Gebski, Adina Borsaru, Christopher Desmond, Michael Swan, Brendan J. Jenkins, Daniel Croagh |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 11% |
France | 1 | 11% |
Italy | 1 | 11% |
Unknown | 6 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Practitioners (doctors, other healthcare professionals) | 3 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 4 | 27% |
Researcher | 1 | 7% |
Student > Postgraduate | 1 | 7% |
Student > Doctoral Student | 1 | 7% |
Student > Master | 1 | 7% |
Other | 0 | 0% |
Unknown | 7 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 4 | 27% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 13% |
Biochemistry, Genetics and Molecular Biology | 1 | 7% |
Medicine and Dentistry | 1 | 7% |
Unknown | 7 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2021.
All research outputs
#7,649,446
of 26,181,776 outputs
Outputs from Frontiers in oncology
#2,726
of 22,924 outputs
Outputs of similar age
#163,116
of 528,428 outputs
Outputs of similar age from Frontiers in oncology
#131
of 1,351 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,428 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 1,351 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.